Archives: ClinicalChallenge

Uncategorized

Management of a Patient With Wet Age-Related Macular Degeneration

Anti-vascular endothelial growth factor agents are an appropriate first-line treatment for neovascular age-related macular degeneration, but aflibercept and ranibizumab do not appear to yield significantly different visual and anatomic outcomes.